The overall incidence rate of BM in patients withanaplastic lymphoma kinase (ALK)‐positive NSCLC is high.85, 86, 87 Some studies have shown that patients with ALK overexpression mutations have stable or asymptomatic BM at the initial diagnosis or with progression. Here, ALK is linked to non-small cell lung carcinoma.